GlassScriptPhysician profile
Leon K Specthrie
NPI 1043295520
$229.86
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.36 · 2022: $43.96 · 2023: $76.86 · 2024: $96.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.01 | 2020-2024 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $31.30 | 2023 | Entyvio |
| Organogenesis INC. | $29.46 | 2024 | Puraply Franchise |
| Janssen Biotech, INC. | $20.38 | 2024 | Stelara, Simponi, Tremfya |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2024 | Exparel |
| Braintree Laboratories, INC. | $16.25 | 2023 | Suflave |
| Rayner Intraocular Lenses Limited | $15.47 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Redhill Biopharma INC. | $14.96 | 2022 | |
| Lilly USA, LLC | $14.14 | 2024 | Omvoh |
| Genentech USA, INC. | $13.84 | 2023 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Specthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.